Although integrin b 3 is known to play an important role in melanoma progression and invasion, regulation of integrin b 3 expression in melanoma has not been analysed in detail until today. As transcriptional regulation of integrin b 3 was ruled out by our analysis, we concentrated on the regulation by microRNAs (miRNAs) . Comparing primary melanocytes and malignant melanoma cell lines, we found that one candidate miRNA, miR-let-7a, was lost in melanoma and sequence analysis suggested an interaction with the 3 0 -untranslated region (3 0 -UTR) of integrin b 3 mRNA. Transfection of melanoma cells with let-7a pre-miR TM molecules resulted in the downregulation of integrin b 3 mRNA and protein expression. In addition, we cloned the 3 0 -UTR of the integrin b 3 mRNA containing the let-7a target sequence into a reporter plasmid and revealed that let-7a negatively regulates reporter gene expression. The repressed expression of integrin b 3 accompanies with reduced invasive potential of melanoma cells transfected with synthetic let-7a molecules observed in Boyden chamber assays. On the other hand, the induction of integrin b 3 expression was achieved in melanocytes by transfection with let-7a anti-miRs, resulting in invasive behavior of transfected melanocytes. In summary, we determined miRNA let-7a to be an important regulator of integrin b 3 expression and showed that the loss of let-7a expression is involved in development and progression of malignant melanoma.
Introduction
Malignant melanoma is the most aggressive form of skin cancer with a more than six-fold increase in incidence over the past 50 years and an estimated figure of about 132 000 cases worldwide annually according to the World Health Organization (WHO). Cutaneous melanoma is arguably the most widely metastasizing neoplastic disease, whereas the disposition to build metastases is a very early event in the progression of this disease.
One of the important proteins implicated in the metastatic potential of melanoma cells is integrin b 3 . Expression as classical vitronectin receptor occurs in a number of tissues when the integrin b 3 subunit pairs with an a V subunit. Upregulation of a V b 3 expression has been associated with malignant potential, which among others appears during the transition from dysplastic nevi to tumorigenic melanomas (Haass et al., 2005) and the neovascularization of tumors (Brooks et al., 1994) . Despite of the knowledge that alterations of the integrin b 3 expression are strongly associated with the acquisition of invasive and/or metastatic properties by human cancer cells in general and melanoma cells in particular , only little is known about the biochemical mechanisms that regulate expression of the integrin b 3 gene in cells. Experiments with reporter constructs containing regions upstream of the integrin b 3 transcription start showed that there is (1) a megakaryocytic cell-line-specific cis-acting element that regulates integrin b 3 expression in megakaryocytic cell lines, but is not effective in regulating the expression of integrin b 3 in endothelial and melanoma cell lines and (2) a sequence that is involved in the regulation of integrin b 3 also in the melanoma cell line WM793, most likely through the Sp1 transcription factor (Jin et al., 1998) . Another study was able to show that sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase (ERK) signaling pathway induces integrin b 3 gene expression in NIH 3T3 cells (Woods et al., 2001) .
The discovery of a new class of small non-coding RNAs-the so-called microRNAs (miRNAs)-not long ago opened up another possible mechanism for regulating gene expression. Those miRNAs, about 18-24 nucleotides in length after fully processed induce post-transcriptional silencing of target genes by binding with imperfect complementary to target sequences in the 3 0 -untranslated region (UTR) of target mRNAs (reviewed in Kim, 2005; Hwang and Mendell, 2006) . We aimed to analyse by which mechanism(s) integrin b 3 expression is regulated in melanocytes and melanoma cell lines. Besides investigating a possible promoter-dependent regulation, we turned our attention on linking integrin b 3 expression regulation to the miRNA pathway of post-transcriptional gene silencing by RNA interference.
Results and discussion
Integrin b 3 is overexpressed in melanoma Several studies presented integrin b 3 to be strongly upregulated in malignant melanoma and were correlating expression to aggressive growth of the tumor (Albelda et al., 1990; Danen et al., 1994 Danen et al., , 1995 Van Belle et al., 1999) . Analysing expression of integrin b 3 in eight melanoma cell lines in comparison to primary melanocytes by quantitative RT-PCR (qRT-PCR) and western blotting clearly confirmed the recent findings (Figures 1a and b) . Although integrin b 3 mRNA was only hardly detectable by qRT-PCR in RNA isolations of primary melanocytes, all of the tested melanoma cell lines (four primary tumor cell lines and four metastatic cell lines) showed an about 10-to 50-fold increase in the expression of integrin b 3 mRNA. No integrin b 3 protein could be detected in protein lysates of primary melanocytes by western blot experiments, whereas all melanoma cell lines gave rise to strong signals with the integrin b 3 primary antibody.
By stable transfection of HMB2 melanoma cells with an antisense-melanoma inhibitory activity (MIA) cDNA expression plasmid, our group recently generated MIA-deficient melanoma cell clones (Poser et al., 2004; Tatzel et al., 2005) . MIA-deficient melanoma cell clones HMB2-MIA5 and HMB2-MIA8 showed a melanocytic growth pattern and gene expression patterns similar to melanocytes as detected by cDNA and protein array experiments. Hence the HMB2/HMB2-MIA cell system serves as model system for investigating molecular differences between 'melanocytes' and melanoma cells in our lab. The big advantage of HMB2-MIA cells in comparison to primary melanocytes is that they can be much more efficiently transfected. qRT-PCR and western blot showed that neither on RNA nor on protein level integrin b 3 could be detected in the MIA deficient-melanoma cell clones HMB2-MIA5 and HMB2-MIA8, whereas control-transfected HMB2 cells containing the empty expression vector (HMB2 lacZ) showed integrin b 3 expression levels similar to parental HMB2 cells (Figures 1c and d) .
As regulation of integrin b 3 expression in malignant melanoma in detail is unknown until today, we aimed to carefully analyse this process. First, we concentrated on the integrin b 3 promoter region. This region was recently described to strictly control the transcription of integrin b 3 in megakaryocytic cell lines (K562, Dami and HEL) and in WM793 melanoma cells (Jin et al., 1998) . We transfected two promoter constructs different in length into melanoma cell line HMB2 and the MIA-deficient HMB2 cell clone HMB2-MIA5 and subsequently performed luciferase assays. Comparing malignant melanoma cell lines HMB2 and the MIA-deficient cell clone HMB2-MIA5 only a small difference in expression of a reporter plasmid containing the integrin b 3 promoter sequence could be observed (Figure 1e ). Although the MIA-deficient cell clone HMB2-MIA5 did not show integrin b 3 expression either on RNA or on protein level, the activity of the integrin b 3 promoter is high in this cell line, displayed by an expression of the luciferase gene of the reporter plasmids about 10 times stronger than by the pGL3 basic vector used as a control.
miRNAs potentially regulating integrin b 3 expression As expression of integrin b 3 was not found to be regulated on transcriptional level on the basis of a 'yes/no' decision, we concentrated on detecting miRNAs potentially regulating integrin b 3 expression. Using three different software attempts (miRanda, Griffiths-Jones et al., 2006; TargetScan S, Lewis et al., 2003; PicTar-Vert, Krek et al., 2005) , several candidate miRNAs for integrin b 3 regulation were determined (miR-30, let-7a, miR-202, miR-290, miR-125 and miR-98) . Array analysis and qRT-PCR was performed to analyse the expression of candidate miRNAs in melanoma cell lines, when compared with primary melanocytes. MiRNA let-7a was shown to be strongly expressed in melanocytes and strongly downregulated or lost in all tested malignant melanoma cell lines (Figure 2a ). This is also true for the HMB2/HMB2-MIA cell system with HMB2 and HMB2 lacZ cells almost completely lacking let-7a expression and a high level of let-7a miRNA in the MIA-deficient melanoma cell lines HMB2-MIA5 and HMB2-MIA8 (Figure 2b ).
Other potential candidate miRNAs for integrin b 3 regulation were not shown to be differentially regulated in a manner fitting the hypothesis that the integrin b 3 regulating miRNA has to be highly expressed in primary melanocytes and almost or completely absent in malignant melanoma cell lines (data not shown).
We also isolated enriched small RNA fractions containing miRNAs from cryopreserved melanoma primary tumor samples. It is well known that melanoma primary tumors show high integrin b 3 levels (Albelda et al., 1990; Danen et al., 1994 Danen et al., , 1995 Van Belle et al., 1999) . In accordance with that we were not able to detect a significant expression of let-7a miRNA in the four melanoma primary tumor samples tested (Figure 2c ).
let-7a is regulating integrin b 3 expression
To confirm the regulation of integrin b 3 by miRNA let-7a, we transfected the two melanoma cell lines Mel Im and Mel Juso with let-7a pre-miRs TM . If the high level of integrin b 3 expression in melanoma cell lines is due to low endogenous let-7a expression in those cells, introducing artificial let-7a molecules (or more precisely molecules that mimic mature let-7a miRNA) should end up in suppressing integrin b 3 expression. As Ras homologs were recently described as targets for let-7a miRNA (Johnson et al., 2005) , successful transfection and activity were confirmed by measuring the regulation of N-Ras mRNA expression. qRT-PCR revealed strong reduction of N-Ras mRNA expression in both melanoma cell lines after let-7a pre-miR TM transfection (Figure 3a ). and SkMel 28). Integrin b 3 levels are about 10-to 50-fold higher in melanoma cell lines than in NHEMs. Enriched small RNA species containing miRNAs and total cellular RNA were isolated from cultured cells using the mirVanat miRNA Isolation Kit (Ambion, Austin, TX, USA). cDNAs of the total RNA fraction were generated using SuperScript II Reverse Transcriptase Kit (Invitrogen, Groningen, The Netherlands). Quantitative real-time PCR was performed on a Lightcycler (Roche, Mannheim, Germany). cDNA template (1 ml), 0.5 ml (20 mM) of forward and reverse primers and 10 ml of Sybr Premix Ex Taq (TaKaRa, Shiga, Japan) were mixed to a total of 20 ml (see Supplementary information for primer sequences and PCR programs). b-Actin was used for normalization. , 1998) were performed as described previously (Rothhammer et al., 2005) . All transfections were repeated at least three times.
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We then analysed integrin b 3 expression after let-7a premiR TM transfection and observed strong reduction in the integrin b 3 mRNA (Figure 3b ). We were also able to show a reduction in integrin b 3 protein performing western blot analysis with pre-miR TM -transfected Mel Im cells in comparison with negative control-transfected cells (Figure 3c ). Anti-miRs are chemically modified oligonucleotides that bind to mature miRNA molecules and through this prevent binding of the miRNA to its target mRNA so that no suppression of gene expression can occur (Krutzfeldt et al., 2005) . In accordance to the above-mentioned results, transfection of MIA-deficient cell clone HMB2-MIA5 with let-7a anti-miRs resulted in a strong increase in both N-Ras and integrin b 3 mRNA-levels (Figures 3d and e ; right-hand bars). The same is true for anti-miR-transfected melanocytes (Figures 3d and e ; left-hand bars). Induction of integrin b 3 protein production in anti-miR-transfected HMB2-MIA5 cells could be shown in western blots (Figure 3f ). These results revealed that inhibition of the endogenous available let-7a molecules in primary melanocytes and HMB2-MIA5 cells by anti-miRs leads to an induction of integrin b 3 mRNA and protein expression in those cells.
To finally rule out that downregulation of integrin b 3 expression after transfection of melanoma cells with let-7a pre-miRs TM is a secondary effect caused by the repression of N-Ras, we knocked down N-Ras by transfecting melanoma cells with small interfering RNAs (siRNAs) against N-Ras. Integrin b 3 expression was only slightly downregulated in N-Ras siRNAtransfected cells, whereas expression was again reduced to about 50% if cells were co-transfected with let-7a pre-miRs TM (Figures 3g and h ). Only very week expression of miRNA let-7a is detectable in melanoma cell lines, whereas let-7a is strongly expressed in NHEMs with an about 30-fold higher level of let-7a miRNA, when compared with malignant melanoma cell line Mel Im. MiRNAs isolated using an mirVana miRNA Isolation Kit (Ambion) were reverse transcribed using the RT reaction set up of a mirVana qRT-PCR miRNA Detection Kit (Ambion). Quantitative real-time PCR of reversetranscribed miRNAs was performed by adding cDNA template (1 ml), 1 ml miRNA-specific PCR primers (Ambion) and 10 ml of Sybr Premix Ex Taq (TaKaRa) in a total of 20 ml (for PCR programs see Supplementary information). 5S-rRNA was used for normalization. (b) Expression of miRNA let-7a in malignant melanoma cell line HMB2, control-transfected HMB2 lacZ cells and MIA-deficient HMB2 cell clones HMB2-MIA5 and HMB2-MIA8. let-7a expression in HMB2 cells is set to 1. The MIA-deficient HMB2 cell clones show an about 15-to 18-fold higher expression of miRNA let-7a, when compared with parental HMB2 cells.
(c) Expression of let-7a miRNA in four cryopreserved primary melanoma tumor samples compared with expression in NHEMs detected by qRT-PCR with primers specific for miRNA let-7a. let-7a expression could not be detected in three of the tissue samples, only one sample shows let-7a expression at a very low level (about 1% of NHEMs in cell culture). 0 -UTR Regulation of integrin b 3 by miRNA let-7a is hypothesized to be modulated by a target sequence in the 3 0 -UTR of the integrin b 3 mRNA. We amplified a 631-bp fragment of the 3 0 -UTR of the integrin b 3 transcript containing the predicted target sequence and ligated it into pGL3 control reporter vector. pGL3 control features SV40 promoter and enhancer sequences, resulting in strong expression of the firefly luciferase gene in most mammalian cells. If expression of integrin b 3 is regulated by the interaction of let-7a with a target sequence in the 3 0 -UTR of its transcript, one would expect the luciferase gene to be highly expressed in cells almost or completely lacking let-7a (as in melanoma cell lines), whereas weak expression should be found in cells with a high level of endogenous let-7a (as in melanocytes and MIA-deficient HMB2-MIA5 cells). In accordance with those expectations, we could show that normal human epidermal melanocytes display an about 85% lower luciferase expression when transfected with our integrin b 3 3 0 -UTR reporter construct, when compared with analogous-transfected Mel Im cells (Figure 4a ). In addition, HMB2-MIA5 cells show an about 62% reduced expression of the ITGB3 3 0 -UTR construct, when compared with parental HMB2 cells (Figure 4b ). Introducing a mutation (exchange of two nucleotides) into the hsa-let-7a target site led to an increase of luciferase expression of 70% ( ± 5%) in HMB2-MIA5 cells compared with the wild-type 3 0 -UTR construct. Furthermore, co-transfection of the reporter plasmid in combination with artificial let-7a pre-miRt molecules in a cell line deficient of endogenous let-7a should lead to a reduced expression of the reporter plasmid compared with cells transfected only with the reporter plasmid. In contrast, co-transfection of the reporter plasmid in combination with let-7a anti-miR molecules in a cell line highly expressing let-7a should lead to an increase in luciferase expression. In fact, Mel Im cells showed an about 25% reduced expression of the reporter gene when co-transfected with let-7a pre-miRs TM compared with cells co-transfected with negative control premiR TM molecules (Figure 4c , left-hand bars). Also fitting our expectations, luciferase expression was increased to about 125% in melanocytes co-transfected with let-7a anti-miRs compared with cells co-transfected with negative control anti-miR molecules (Figure 4c , righthand bars). The relatively small effect of about 25% regulation in both directions when co-transfecting the 3 0 -UTR reporter construct, together with synthetic let7a pre-miRs and anti-miRs, respectively, is likely due to a low efficiency of our transfection system when used for co-transfecting plasmids along with synthetic small RNA molecules.
let-7a has strong impact on the invasive potential of melanoma cells
To examine the effect of miRNA let-7a on the invasive potential of melanoma cells, we transfected malignant melanoma cell line Mel Im with let-7a pre-miRs TM and a negative control miR and subjected those cells Boyden chamber assays. Mel Im cells transfected with let-7a pre-miRs TM showed significantly reduced invasiveness compared with Mock-transfected and negative control transfected cells (Figure 5a ). We then wanted to know if it is possible to induce migratory behavior in primary TM and anti-miR (Ambion) was performed using 18 ml HiPerFect transfection reagent (Qiagen, Hilden, Germany) each well in six-well plates. Ambion's negative-control miR #1 and negative-anti-miR served as negative controls. Double transfection was performed at 0 and 24 h. Total RNA and protein were isolated 48 h after the first transfection using a Nucelobond kit (Macherey-Nagel, Du¨ren, Germany). It is to mention that Ambions' 'pre-miR TM ' molecules are actually molecules similar to siRNAs mimicking the mature miRNA rather than a real miRNA precursor molecule. We therefore refer to the molecules as pre-miRs TM in the text to indicate the nature of the molecules distributed by Ambion. Normal human epidermal melanocytes (NHEMs) were tranfected using an Amaxa Nucleofector device and an NHEM-Neo Nucleofector Kit (Amaxa, Cologne, Germany). A total of 50 nmol of anti-miR and negative-anti-miR (Ambion) were transfected. Total RNA and protein were isolated 24 h after transfection using a Nucelobond kit (Macherey-Nagel). (g) N-Ras expression is knocked down to about 10% in Mel Im cells transfected with each of two different siRNAs against N-Ras compared with negative control siRNAtransfected cells (left-hand bars). If co-transfection of the siRNAs together with let-7a pre-miRs TM was performed, N-Ras was knocked down to about 20% in the mean (right-hand bars). (h) Only a slight decrease in integrin b 3 expression could be observed after treatment with N-Ras siRNAs (left-hand bars), whereas after co-transfection, together with let-7a pre-miRs TM , integrin b 3 expression was reduced to about 50% compared with double-negative control-transfected cells (right-hand bars). N-Ras siRNA transfections and N-Ras siRNA/let-7a pre-miR TM co-transfections were also performed using HiPerFect and Qiagen's N-Ras siRNAs #5 and #6 with the corresponding negative control siRNA.
melanocytes by blocking the function of endogenous let-7a molecules by transfection with let-7a anti-miRs. Although enhanced migration of normal human epidermal melanocytes was already observed in negative control-transfected cells, indicating an activating influence of the transfection procedure itself, melanocytes transfected with let-7a anti-miRs showed strongly increased migration (about two times higher than negative control-transfected cells; Figure 5b) .
In our study, we aimed to unravel the mechanism(s) regulating integrin b 3 expression in melanocytes and melanoma cells, covering analysis of promoter-dependent regulation and investigation of a possible link to the miRNA pathway of RNA interference.
In contrast to Jin et al. (1998) , we can state that promoter-dependent regulation plays only a minor role in controlling integrin b 3 expression, but is not the basis for the cellular decision for protein expression in the studied cell lines.
In silico prediction of miRNAs possibly binding to target sequences in the 3 0 -UTR of integrin b 3 mRNA displayed let-7a, a candidate miRNA for regulating integrin b 3 expression. In accordance with recent publications on strongly decreased let-7a levels in various cancer cell lines compared with the related normal cell lines (Gaur et al., 2007; Porkka et al., 2007; Zhang et al., 2007) , we were able to show that the expression of let-7a miRNA is strongly downregulated or even lost in the analysed melanoma cell lines, when compared with normal human epidermal melanocytes. Interestingly, this correlates with strong integrin b 3 expression in melanoma cells and only weak or undetectable integrin b 3 expression in melanocytes. Furthermore, we were able to show that let-7a expression is lost in melanoma primary tumors, 0 -UTR reporter construct with artificial let-7a pre-miR TM molecules into Mel Im melanoma cell line results in an about 25% downregulation of luciferase activity compared with cells co-transfected with the 3 0 -UTR construct and negative control pre-miR TM molecules. Co-transfection of the integrin b 3 3 0 -UTR reporter construct with let-7a anti-miR molecules into normal human epidermal melanocytes results in an about 25% upregulation of luciferase activity compared with cells co-transfected with the 3 0 -UTR construct and negative control anti-miR molecules. For generating the ITGB3_3 0 -UTR reporter construct, a 631-bp fragment of the integrin b 3 3 0 -UTR containing the predicted let-7a target sequence was cloned into pGL3 control vector (Promega, Mannheim, Germany) by using an XbaI restriction site. In addition, a reporter plasmid containing the integrin b 3 3 0 -UTR with a mutated hsa-let-7a target sequence was created using a QuickChange Site-Directed Mutagenesis Kit (Stratagene, Amsterdam, The Netherlands). See Supplementary information for primer sequences and PCR programs.
which are well known for their high content of integrin b 3 (Albelda et al., 1990; Danen et al., 1994 Danen et al., , 1995 Van Belle et al., 1999) . In our study, we linked the regulation of integrin b 3 to the amount of miRNA let-7a present in the cell, as the integrin b 3 mRNA level showed antipodal down/ upregulation when cells were transfected with pre-miRs and anti-miRs, respectively. In addition, we were able to prove direct interaction of miRNA let-7a and the predicted target sequence in the 3 0 -UTR of the integrin b 3 transcript by creating reporter constructs containing the integrin b 3 3 0 -UTR with either the intact or a mutated hsa-let-7a target site behind a luciferase gene.
Repression of the luciferase expression in cells with a high endogenous let-7a level was partly eliminated by mutating the let-7a target sequence in the integrin b 3 3 0 -UTR. These results clearly show that miRNA let-7a has a much more dramatic effect on integrin b 3 expression in our cell lines than promoter-dependent mechanisms do have. Woods et al. (2001) published that the activation of integrin b 3 expression is induced by sustained activation of the Ras-regulated Raf-MEK-ERK signaling pathway in NIH 3T3 cells. Direct regulation of the integrin b 3 promoter by ERK-activated transcription factors can be ruled out by our promoter analysis. Potential regulation of let-7a expression by ERK activation has to be analysed in subsequent studies.
In our study, miRNA let-7a was shown to be a tumor suppressor gene as it represses expression of the N-Ras oncogene and integrin b 3 , proteins strongly involved in melanoma progression and invasion. This fact gets even more interesting considering that the two target genes are important constituents of very different subgroups of cellular processes. N-Ras is highly involved in processes dealing with cell proliferation, whereas integrin b 3 is related to cell adhesion and migration. This fact assigns an important role to miRNA let-7a in formation and progression of malignant melanoma as two steps critical in tumorigenesis are affected. On the one hand, missing suppression of Ras expression contributes to unrestricted cell division events. On the other hand, missing suppression of integrin b 3 enhances the migratory potential and invasiveness of tumor cells, ultimately leading to the formation of metastases in distinct organs. This fact is also supported by the regulation of HMGA-2, another proto-oncogene, by let-7a (Park et al., 2007) . Therefore, loss of let-7a expression has extremely extensive effects on transformation of melanocytes to melanoma cells. This gives miRNA let-7a also a possible therapeutic relevance, as we were able to show that the invasiveness of melanoma cells can be strongly (about 75%) reduced when transfecting the cells with let-7a pre-miR TM molecules; thus reconstituting the suppressive impact in cells lacking endogenous let-7a. NHEMs show an about two times higher migratory potential after transfection with let-7a anti-miRs than negative control-transfected cells. The transfection procedure itself seems to have an activating effect on migratory behavior of NHEMs. Invasion and migration assays were performed using Boyden chambers essentially as described previously (Rothhammer et al., 2005) . After incubation at 37 1C for 4 h, the filters were collected, and the cells adhering to the lower surface fixed, stained and counted.
